CAS 167074-97-7
:10-Oxo Docetaxel
10-Oxo Docetaxel
CAS:10-Oxo Docetaxel is a Docetaxel intermediate having remarkable antitumor properties.Formula:C43H51NO14Purezza:98%Colore e forma:SolidPeso molecolare:805.87410-Oxo docetaxel
CAS:Impurity Docetaxel EP Impurity B
Stability Epimerize in solution
Applications 10-Oxo Docetaxel (Docetaxel EP Impurity B) is a novel taxoid having remarkable anti-tumor properties. Docetaxel (D494420) intermediate. This product is unstable in solution, epimerize.
References Appendino, G., et al.: Tetrahedron Lett., 37, 7836 (1996),Formula:C43H51NO14Colore e forma:WhitePeso molecolare:805.86Ref: ST-EA-CP-D32002
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta6-Oxo Docetaxel
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C43H51NO14Colore e forma:White PowderPeso molecolare:805.3309610-Oxo docetaxel
CAS:10-Oxo docetaxel is a taxane that is used in the treatment of cancer. It has shown to be effective in the treatment of breast, lung, prostate, and bladder cancers. The impurities of this drug are 10-deacetylbaccatin III (10-DAB) and 10-deacetyltaxol (10-DT). These impurities can be quantified using LC/MS/MS methods with a limit of detection at 0.05% for 10-DAB and 0.1% for 10-DT. The limits of quantification are determined by the peak area response and signal to noise ratio. Bortezomib is an impurity that cannot be removed by chromatographic methods but can be removed by supercritical CO2 extraction. This impurity may cause significant adverse effects on patients receiving this drug as bortezomib inhibits the proteasome which is needed to break down proteins within cells that are damaged or no
Formula:C43H51NO14Purezza:Min. 95%Colore e forma:White PowderPeso molecolare:805.86 g/molRef: 3D-FO26648
Prodotto fuori produzione








